# Phase 10: Review and ADR - Context

**Gathered:** 2026-02-20
**Status:** Ready for planning

<domain>
## Phase Boundary

Review experiment data (6 JSONL files, 120 total results across baseline and app-like variants) and produce a defensible ADR with ADOPT/REJECT/REVISIT decision on tool interface strategy. Must follow blind review protocol — read transcripts before aggregate stats.

</domain>

<decisions>
## Implementation Decisions

### Claude's Discretion

All areas delegated to Claude's judgment:

**Review process:**
- How to structure the blind review (ordering, batching)
- Whether to review all 120 transcripts or use strategic sampling
- Tool choice: LangSmith traces, JSONL directly, Claude Code batch review, or combination
- How to record per-transcript observations

**Evaluation criteria:**
- Quality dimensions to assess (correctness, naturalness, ambiguity handling, tool selection)
- How to weight different quality dimensions
- What constitutes a "failure" vs "acceptable" vs "good" response

**ADR format and decision threshold:**
- Evidence threshold for ADOPT vs REJECT vs REVISIT
- ADR structure and level of detail
- How to present evidence (example transcripts, aggregate tables, both)

**Post-decision scope:**
- How to translate ADR conclusion into actionable next steps
- Whether to include migration plan in the ADR or defer to next milestone

</decisions>

<specifics>
## Specific Ideas

No specific requirements — open to standard approaches.

Constraints from ROADMAP.md success criteria:
1. Every failure transcript must be read by a human — no conclusions from aggregate stats alone
2. Blind protocol: read transcripts before looking at aggregate pass rates
3. ADR must document hypothesis, methodology, results, and clear decision

</specifics>

<deferred>
## Deferred Ideas

None — discussion stayed within phase scope.

</deferred>

---

*Phase: 10-review-and-adr*
*Context gathered: 2026-02-20*
